Related Experiment Video

Updated: May 24, 2026

Detecting Protein Subcellular Localization by Green Fluorescence Protein Tagging and 4',6-Diamidino-2-phenylindole Staining in Caenorhabditis elegans
09:36

Detecting Protein Subcellular Localization by Green Fluorescence Protein Tagging and 4',6-Diamidino-2-phenylindole Staining in Caenorhabditis elegans

Published on: July 30, 2018

Translational control of cell fate: from integration of environmental signals to breaching anticancer defense

Peter B Bitterman1, Vitaly A Polunovsky

  • 1Department of Medicine and Masonic Cancer Center, University of Minnesota; Minneapolis, MN, USA.

Cell Cycle (Georgetown, Tex.)
|February 24, 2012
PubMed

Insights

Cancer cells hijack the eIF4F translation initiation complex to promote growth and evade surveillance. Targeting this complex with small-molecule antagonists offers a novel therapeutic strategy for cancer treatment.

Area of Science:

  • Molecular biology
  • Cancer research
  • Biochemistry

Background:

  • Cancers, despite genetic diversity, share common protein pathway perturbations.
  • These pathways converge on regulatory hubs linking cell signaling and metabolism.
  • The eIF4F complex, crucial for mRNA translation, is implicated in cancer progression.

Purpose of the Study:

  • To model the pro-neoplastic function of eIF4F.
  • To link eIF4F activity to the evasion of tumor surveillance.
  • To propose a novel therapeutic strategy targeting eIF4F.

Main Methods:

  • Analysis of protein pathway perturbations in cancer.
  • Modeling the role of eIF4F in cancer genesis.
  • Investigating eIF4F's interaction with oncogenic signaling and tumor surveillance.

Main Results:

  • A model demonstrating eIF4F's role in promoting cancer by disabling tumor surveillance.
  • Identification of eIF4F as a key regulatory hub in cancer.
  • Evidence supporting eIF4F's selective translation of cancer-promoting mRNAs.

Conclusions:

  • Aberrant eIF4F activation is a key driver of cancer progression.
  • Targeting eIF4F with small-molecule antagonists is a promising therapeutic strategy.
  • Disabling eIF4F may restore tumor surveillance mechanisms.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...